A detailed history of Osterweis Capital Management Inc transactions in Natera, Inc. stock. As of the latest transaction made, Osterweis Capital Management Inc holds 75,910 shares of NTRA stock, worth $12.7 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
75,910
Previous 84,820 10.5%
Holding current value
$12.7 Million
Previous $9.19 Million 5.04%
% of portfolio
0.58%
Previous 0.59%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $870,952 - $1.16 Million
-8,910 Reduced 10.5%
75,910 $9.65 Million
Q2 2024

Aug 14, 2024

SELL
$85.28 - $112.6 $489,507 - $646,324
-5,740 Reduced 6.34%
84,820 $9.19 Million
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $160,459 - $251,759
2,710 Added 3.08%
90,560 $8.28 Million
Q4 2023

Feb 14, 2024

BUY
$37.55 - $62.64 $276,743 - $461,656
7,370 Added 9.16%
87,850 $5.5 Million
Q3 2023

Nov 14, 2023

BUY
$43.4 - $62.52 $66,185 - $95,343
1,525 Added 1.93%
80,480 $3.56 Million
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $601,447 - $704,669
12,775 Added 19.3%
78,955 $3.84 Million
Q1 2023

May 15, 2023

BUY
$36.57 - $58.29 $910,593 - $1.45 Million
24,900 Added 60.32%
66,180 $3.67 Million
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $1.41 Million - $1.98 Million
41,280 New
41,280 $1.66 Million
Q1 2022

May 16, 2022

SELL
$30.32 - $91.33 $539,847 - $1.63 Million
-17,805 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$86.26 - $119.0 $4.04 Million - $5.58 Million
-46,860 Reduced 72.47%
17,805 $1.66 Million
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $2.93 Million - $3.69 Million
29,205 Added 82.36%
64,665 $7.21 Million
Q2 2021

Aug 16, 2021

BUY
$86.05 - $119.72 $3.05 Million - $4.25 Million
35,460 New
35,460 $4.03 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Osterweis Capital Management Inc Portfolio

Follow Osterweis Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Osterweis Capital Management Inc with notifications on news.